Ro 0281675
| CAS No. | 300353-13-3 | Cat. No. | BCP16457 |
| Name | Ro 0281675 | ||
| Synonyms | Ro-0281675;Ro0281675; Ro 28-1675; | ||
| Formula | C18H22N2O3S2 | M. Wt | 378.51 |
| Description | IC50 value: 0.24± 0.0019 uM (SC1.5) Target: Glucokinase activator The R stereoisomer Ro 28-1675 activated GK with a SC1.5 of 0.24 uM, while the S isomer did not activated GK up to 10 uM. Oral administration of Ro 28-1675 (50 mg/Kg) to male C57B1/6J mice caused a statistically significant reduction in fasting glucose levels and improvement in glucose tolerance relative to the vehicle treated animals . Comparison of rat PK parameters indicated that Ro 28-1675 displayed lower clearance and higher oral bioavailability compared to 9a. Following a single oral dose, Ro 28-1675 reduced fasting and postprandial glucose levels following an OGTT, was well tolerated, and displayed no adverse effects related to drug administration other than hypoglycemia at the maximum dose (400 mg). | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Glucokinase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.